Literature DB >> 2110818

Management of upper airway obstruction in the Pierre Robin syndrome.

A Augarten1, M Sagy, J Yahav, Z Barzilay.   

Abstract

Eight patients with Pierre Robin syndrome (PRS), were treated according to our management protocol. All our patients initially were given a trial of conservative, positional treatment, with high caloric gavage feeding. In five patients this therapeutic approach resulted in a good weight gain, with no significant respiratory distress. The remaining three patients showed no improvement, failed to thrive and therefore underwent the tongue to lip adhesion (TLA) procedure. Two patients then improved dramatically; whereas one continued with respiratory distress and failure to thrive and required tracheostomy. We conclude that when symptoms of respiratory distress and failure to thrive coexist in patients with PRS despite conservative management, surgical intervention to the airway is mandatory. TLA should be the first surgical procedure considered and if the ultimate goals of weight gain and respiratory comfort are still not achieved then tracheostomy seems inevitable.

Entities:  

Mesh:

Year:  1990        PMID: 2110818     DOI: 10.1016/0266-4356(90)90133-6

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  2 in total

1.  Tongue-lip adhesion in Pierre Robin sequence.

Authors:  K S Krishna Kumar; Suresh Vylopilli; Anand Sivadasan; Ajit Kumar Pati; Saju Narayanan; Santhy Mohanachandran Nair
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-02-15

2.  A pragmatic approach to infants with Robin sequence: a retrospective cohort study and presence of a treatment algorithm.

Authors:  Emma C Paes; Daan P F van Nunen; Lucienne Speleman; Marvick S M Muradin; Bram Smarius; Moshe Kon; Aebele B Mink van der Molen; Aebele B Mink van der Molen; Titia L E M Niers; Esther S Veldhoen; Corstiaan C Breugem
Journal:  Clin Oral Investig       Date:  2015-02-15       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.